These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
188 related items for PubMed ID: 11229787
21. Study designs and outcomes in antidepressant clinical trials. Khan A, Schwartz K. Essent Psychopharmacol; 2005; 6(4):221-6. PubMed ID: 16041918 [Abstract] [Full Text] [Related]
22. From trial and error to trial simulation. Part 2: an appraisal of current beliefs in the design and analysis of clinical trials for antidepressant drugs. Santen G, Horrigan J, Danhof M, Della Pasqua O. Clin Pharmacol Ther; 2009 Sep; 86(3):255-62. PubMed ID: 19675543 [Abstract] [Full Text] [Related]
24. Strategies for producing faster acting antidepressants. Adell A, Castro E, Celada P, Bortolozzi A, Pazos A, Artigas F. Drug Discov Today; 2005 Apr 15; 10(8):578-85. PubMed ID: 15837601 [Abstract] [Full Text] [Related]
26. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial. Jahn H, Schick M, Kiefer F, Kellner M, Yassouridis A, Wiedemann K. Arch Gen Psychiatry; 2004 Dec 15; 61(12):1235-44. PubMed ID: 15583115 [Abstract] [Full Text] [Related]
27. Antidepressants: can we determine how quickly they work? Issues from the literature. Derivan AT. Psychopharmacol Bull; 1995 Dec 15; 31(1):23-8. PubMed ID: 7675984 [Abstract] [Full Text] [Related]
28. Managing treatment-resistant major depression. Nelson JC. J Clin Psychiatry; 2003 Dec 15; 64 Suppl 1():5-12. PubMed ID: 12625799 [Abstract] [Full Text] [Related]
29. Research and methodological issues for evaluating the therapeutic effectiveness of antidepressant drugs. Prien RF, Levine J. Psychopharmacol Bull; 1984 Dec 15; 20(2):250-7. PubMed ID: 6374721 [No Abstract] [Full Text] [Related]
30. The mousetrap: managing the placebo effect in antidepressant trials. Lakoff A. Mol Interv; 2002 Apr 15; 2(2):72-6. PubMed ID: 14993352 [No Abstract] [Full Text] [Related]
32. Rational antidepressant selection in the elderly. Christensen DD. Geriatrics; 1995 Oct 15; 50 Suppl 1():S41-50. PubMed ID: 7493749 [Abstract] [Full Text] [Related]
33. [Evaluation of clinical and psychological methods in estimating antidepressants efficacy in treatment of depression (preliminary report)]. Puzyński S, Koszewska I, Habrat E, Fornal S, Bzinkowska D, Gradzka D, Kalinowski A, Swiecicki Ł, Torbiński J. Psychiatr Pol; 2002 Oct 15; 36(2):225-38. PubMed ID: 12043041 [Abstract] [Full Text] [Related]
34. Resolving the onset of antidepressants' clinical actions: critical for clinical practice and new drug development. Katz MM, Bowden CL, Berman N, Frazer A. J Clin Psychopharmacol; 2006 Dec 15; 26(6):549-53. PubMed ID: 17110809 [No Abstract] [Full Text] [Related]
35. Multidimensional assessment of acute and long-term effects in antidepressant drug trials. Müller-Oerlinghausen B. Pharmacopsychiatry; 1994 Jul 15; 27 Suppl 1():18-20. PubMed ID: 7984692 [Abstract] [Full Text] [Related]
36. Research indicates antidepressants may be best for severe depression. Mayo Clin Womens Healthsource; 2010 Jul 15; 14(7):3. PubMed ID: 20517186 [No Abstract] [Full Text] [Related]
37. Who should receive antidepressants: suggestions from placebo treatment. Khan A, Brown WA. Psychopharmacol Bull; 1991 Jul 15; 27(3):271-4. PubMed ID: 1775597 [Abstract] [Full Text] [Related]
38. Onset, time course and trajectories of improvement with antidepressants. Lam RW. Eur Neuropsychopharmacol; 2012 Jul 15; 22 Suppl 3():S492-8. PubMed ID: 22959114 [Abstract] [Full Text] [Related]